Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.

Baricitinib may effectively treat oral lichen planus.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

5-ARI therapy may help prevent prostate cancer progression.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

WYE-130600 may cause skin thickening and irritation.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

A man developed an allergic skin reaction after using brimonidine for rosacea.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Baricitinib helps treat severe hair loss in people over 65.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.